Figure 4.
Effect of treatment with saline, or control, HRG, or FXII ASOs on time to catheter occlusion and thrombus weight. After a 4-week course of treatment with saline (n = 6 per group), or control, HRG, or FXII ASOs (n = 8 per group), catheters were implanted in the jugular vein and the time to catheter occlusion (A) and the weight of the explanted catheter thrombi (B) were determined. Mean ± SD, with the symbols representing the results in individual rabbits. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001; and ∗∗∗∗P < .0001 comparisons between catheter occlusion times or thrombus weights as indicated by the lines; (one-way ANOVA and Holm-Sidak method). (C) Representative images of explanted catheters with intralumenal thrombi. NS, not significant.

Effect of treatment with saline, or control, HRG, or FXII ASOs on time to catheter occlusion and thrombus weight. After a 4-week course of treatment with saline (n = 6 per group), or control, HRG, or FXII ASOs (n = 8 per group), catheters were implanted in the jugular vein and the time to catheter occlusion (A) and the weight of the explanted catheter thrombi (B) were determined. Mean ± SD, with the symbols representing the results in individual rabbits. P < .05; ∗∗P < .01; ∗∗∗P < .001; and ∗∗∗∗P < .0001 comparisons between catheter occlusion times or thrombus weights as indicated by the lines; (one-way ANOVA and Holm-Sidak method). (C) Representative images of explanted catheters with intralumenal thrombi. NS, not significant.

Close Modal

or Create an Account

Close Modal
Close Modal